1.
Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications
by Touchefeu, Y.
Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (5), p.409-421

2.
Review article: herbal hepatotoxicity – an update on traditional Chinese medicine preparations
by Teschke, R.
Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (1), p.32-50

3.
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program
by Armstrong, M. J.
Alimentary pharmacology & therapeutics, 2013-01, Vol.37 (2), p.234-242

4.
Olmesartan‐associated enteropathy: results of a national survey
by Marthey, L.
Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (9), p.1103-1109

5.
Systematic review: sprue‐like enteropathy associated with olmesartan
by Ianiro, G.
Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (1), p.16-23

6.
Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
by Deepak, P.
Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (4), p.388-396

7.
Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
by Sarnes, Evelyn, PharmD, MPH
Clinical therapeutics, 2011, Vol.33 (10), p.1413-1432

8.
Risk factors of symptomatic NSAID‐induced small intestinal injury and diaphragm disease
by Ishihara, M.
Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (5), p.538-547

9.
Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
by Kakuda, Thomas N
Clinical therapeutics, 2000, Vol.22 (6), p.685-708

10.
Rates of 5 Common Antidepressant Side Effects Among New Adult and Adolescent Cases of Depression: A Retrospective US Claims Study
by Anderson, Heather D., PhD
Clinical therapeutics, 2012, Vol.34 (1), p.113-123

11.
Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea
by Cremonini, F.
Alimentary pharmacology & therapeutics, 2002-08, Vol.16 (8), p.1461-1467

12.
Maternal and foetal adverse events with tumour necrosis factor‐alpha inhibitors in inflammatory bowel disease
by Deepak, P.
Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (9), p.1035-1043

13.
Cumulative Burden of Oral Corticosteroid Adverse Effects and the Economic Implications of Corticosteroid Use in Patients With Systemic Lupus Erythematosus
by Shah, Manan, PharmD, PhD
Clinical therapeutics, 2013, Vol.35 (4), p.486-497

14.
A parametric analysis of olanzapine-induced weight gain in female rats
by COOPER, G. D
Psychopharmacologia, 2005, Vol.181 (1), p.80-89

15.
Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation
by Schmidt, M.
Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.165-174

16.
Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population‐based study
by Lin, C.‐C.
Alimentary pharmacology & therapeutics, 2013-11, Vol.38 (9), p.1119-1128

17.
Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)‐induced human acute liver injury
by Craig, D. G.
Alimentary pharmacology & therapeutics, 2013-12, Vol.38 (11-12), p.1395-1404

18.
Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events
by Scheiman, James M., MD
Clinical therapeutics, 2010, Vol.32 (4), p.667-677

19.
Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes
by DOKKA, S
Pharmaceutical research, 2000, Vol.17 (5), p.521-525

20.
The effects of lithium on cognition: an updated review
by PACHET, Arlin K
Psychopharmacologia, 2003, Vol.170 (3), p.225-234
